NEW_CURA-LEAF_1170x120_OCT

Scott Melville

Texas signs age-restriction law to curb teen cough medicine abuse

Texas signs age-restriction law to curb teen cough medicine abuse

WASHINGTON — On May 17th, Texas Governor Greg Abbott signed into law an age-18 requirement for the purchase of over-the-counter (O-T-C) medicines containing the cough suppressant dextromethorphan (DXM), an ingredient which is abused by some teenagers to get high. Texas is the 19thstate to prohibit the sale of O-T-C cough medicine to minors, joining other

CHPA holds successful 2019 Annual Executive Conference

CHPA holds successful 2019 Annual Executive Conference

WASHINGTON – The Consumer Healthcare Products Association (CHPA) concluded their 2019 Annual Executive Conference, held from March 17-19, at the Boca Raton Resort and Club, in Boca Raton, Fla. More than 300 executives from the over-the-counter (OTC) drug, dietary supplement, and consumer medical device sectors heard from an impressive lineup of speakers, including renowned presidential historian and Pulitzer Prize-winning

Survey shows teen misuse of O-T-C cough medicine remains very low

Survey shows teen misuse of O-T-C cough medicine remains very low

WASHINGTON — The 2018 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that the percentage of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high remains at 3 %. When first reported in 2006, the number of teens abusing O-T-C cough medicines

CHPA welcomes new board members

CHPA welcomes new board members

WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America

CHPA bullish on pending revision of O-T-C monograph policy

CHPA bullish on pending revision of O-T-C monograph policy

WASHINGTON — The stage is set for a regulatory change that will boost innovation by consumer health care products manufacturers, according to leaders of their association. The Food and Drug Administration’s O-T-C monograph system, which hasn’t been updated for over 45 years, is facing massive modernization efforts in the form of pending legislation in both

CHPA urges participation in supplement registry

CHPA urges participation in supplement registry

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has called on members that market dietary supplements to submit product labels to the Supplement Online Wellness Library (OWL) developed by Council for Responsible Nutrition (CRN) and independent safety science firm UL. CRN said the announcement follows talks between CHPA and its Dietary Supplements Committee, which reviewed

Rx switches lead allergy sufferers to OTCs

Rx switches lead allergy sufferers to OTCs

WASHINGTON — More allergy sufferers are opting for over-the-counter medicines to alleviate their symptoms as more prescription products switch to OTC status, according to new research Consumer Healthcare Products Association (CHPA) and Nielsen. CHPA said Thursday the study found that 60% adult allergy sufferers use only OTCs for treatment, up from just more than half

Year of opportunity for OTC medicines

Year of opportunity for OTC medicines

The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome a new American president and Congress, the country is waiting to see how the regulatory and legislative landscape will evolve. But I am certain that one thing will not change: the continued importance of over-the-counter

CHPA hails Georgia for adoption of PSE stop-sale system

CHPA hails Georgia for adoption of PSE stop-sale system

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has applauded Georgia for becoming the 33rd state to adopt real-time, stop-sale technology for illegal purchases of medication containing pseudoephedrine (PSE). Georgia Gov. Nathan Deal last week signed legislation, approved by the state legislature and sponsored by State Rep. David Clark Clark and State Sen. Renee Unterman (R.),

CHPA announces new officers, board members

CHPA announces new officers, board members

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has elected officers and members to its board of directors. CHPA said Wednesday that Patrick Lockwood-Taylor, vice president of Personal Health Care North America and Digestive Wellness Design for Procter & Gamble Co., will continue to serve as chairman. Jeffrey Needham, executive vice president and general manager

CHPA board re-elects P&G exec as chairman

CHPA board re-elects P&G exec as chairman

BONITA SPRINGS, Fla. — Procter & Gamble Co. executive Patrick Lockwood-Taylor has been re-elected as chairman of the Consumer Healthcare Products Association (CHPA) board of directors. Lockwood-Taylor, who is vice president of personal health care for North America and digestive wellness design at Procter & Gamble, was named chairman at CHPA’s 2015 Annual Executive Conference,

CHPA backs bill to repeal FSA restriction on OTCs

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has endorsed the Restoring Access to Medicines Act of 2015 (H.R. 1270), which would make it easier for consumers to use medical savings account funds to buy over-the-counter medicines. CHPA said Thursday that the bill, introduced in the House of Representatives by Reps. Lynn Jenkins (R., Kan.)